Transcripta Bio (Series A)
Funding Details
Awarder
Inbox
Date Award
July 22, 2026
Vertical
Biotechnology
Funding Amount
$24,000,000
Company Info
Market
Neurological and neuromuscular diseases
Location
Palo Alto, CA, USA
Coinvestors
BlueYard Capital, Jazz Venture Partners, Mayo Clinic Ventures, Omnimed Capital
Company Description

Transcripta Bio is an AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases. The company's closed-loop discovery engine uses transcriptomic signature matching to identify drug candidates whose molecular signatures are the inverse of patient-derived disease signatures, enabling a faster, more capital-efficient path to the clinic.

Links